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Undoubtedly, the current century is witness to an unprecedented speed in advancements 
within biological sciences, which are owed to the immense technological progress in the 
analytical tools and methods utilized, and to the dawn of the fast developing fields of omics 
and bioinformatics. Omics allows the collection of holistic data on several different 
biomolecule classes, and bioinformatics makes it possible to explore and understand the 
vast amounts of data produced. The most mature omics fields, in terms of both hardware 
and software, are genomics and transcriptomics, based on next generation sequencing 
(NGS) technologies. With the introduction of electrospray ionization and high-resolution 
mass spectrometry, liquid chromatography coupled to tandem mass spectrometry (LC-
MS/MS), has made significant leaps for the fields of metabolomics and proteomics. 
One promising method for LC-MS/MS-based proteomics is data independent 
acquisition (DIA), which requires advanced data analysis algorithms. MaxDIA, within the 
MaxQuant software for the processing of LC-MS/MS-based proteomics data, is introduced 
here. It comes with an accurate false discovery rate estimation of the peptide and protein 
identification based on measured and predicted spectrum libraries. When compared to the 
state of the art, MaxDIA also delivers comprehensive proteome coverages and lower 
coefficients of variation in protein quantification. 
Bioinformatics tools for the analysis of metabolomics data generally follow the 
same principles and steps as proteomics software, but due the huge numbers of 
metabolites and immense complexity of metabolomics data, much work is still needed to 
bring metabolomics software to the level of maturity of their proteomics equivalents. 
MaxQuant is a time tested and widely accepted software for the processing of proteomics 
data, which was first recognized for its cutting-edge nonlinear recalibration for reaching 
superior precursor mass accuracy, which helps significantly improve peptide 
identifications. Here, following this direction, a new algorithm within MaxQuant for 
improving mass accuracy in metabolomics data is introduced, which utilizes a novel 
metabolite library-based mass recalibration algorithm.  
The many types of omics data available today present a great opportunity for 
developing approaches to combine such data in order to infer new knowledge, often 
termed multi-omics studies. A robust approach to this end is to utilize prior knowledge on 
the relationships of the various major biomolecules in question, which are often depicted 
in network structures where the nodes of the network depict biomolecules and the edges 




plugin for the Perseus software aimed at analyzing quantitative multi-omics data based on 
metabolic pathways. 
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Biological sciences in the current century are becoming an ever more data-driven 
endeavor (MacKlin, 2019). This is both due to the shear increase in the availability of 
vast resources of high-throughput omics data, and also improvements in methods 
and algorithms used for the generation, processing and analysis of such data 
(Chavan, Shaughnessy and Edmondson, 2011; Cox and Mann, 2011; Sinitcyn, 
Rudolph and Cox, 2018). One can say that biological sciences have now truly entered 
the fourth paradigm of science in efforts for the exploration and understanding of 
biological systems (Figure 1.1). This has brought with it a new push to advance a 
dynamic field of research within biology, namely bioinformatics, which has emerged 
to be of central importance in many aspects of novel experimental design, and 
knowledge discovery (Gauthier et al., 2019). Bioinformatics efforts aim to bridge the 
gap between biology and informatics and work to enable biological researchers to 
effectively analyze the data gathered to reach a deeper insight into various aspects of 
living systems (Luscombe, Greenbaum and Gerstein, 2001). 
 
Figure 1.1: Paradigms in biology (adapted from (Agrawal and Choudhary, 2016)). Each 
arrow depicts a paradigm in biology, with an example for a development in that direction. 
Current bioinformatics solutions have been essential in propelling our 
understanding of many aspects of biology, but there still exists a great deal that 
remains to be developed and thus, it is ever more important to focus efforts on novel 
tools and algorithms that can handle such large quantities of highly complex data 
(Fuller et al., 2013; Gauthier et al., 2019). In this introductory chapter, omics are 
discussed in general, along with computational proteomics, computational 
metabolomics, and methods for multi-omics data analysis. 
[Grab your reader’s 
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The capacity to holistically collect data, and study any living entity, ranging from 
single cells to large multicellular organisms, has given way to new fields of study, 
commonly labelled as omics (Karahalil, 2016). Naturally, the generation of large 
omics datasets has brought with it, both a novel set of opportunities, and challenges 
which lay primarily in the realm of bioinformatics (Gauthier et al., 2019). Omics data 
can be generated on different levels in respect to the major biomolecule class in 
question, whether it be DNA (genomics), RNA (transcriptomics), protein 
(proteomics) or metabolite (metabolomics) (Figure 1.2).  
 
Figure 1.2: Different levels of omics based on the major biomolecules studied. 
Genomics is defined as the study of complete sets of genetic material found 
within the cells of an organism, which not only includes both coding and noncoding 
DNA, but also the genetic material found in the mitochondria of most eukaryotic cells 
and chloroplasts in plant and algal cells. Genomics focuses on the study of whole 
genomes with respect to their structure and function, and the impact of variations 
within the genome on various aspects of life. Genomics data consist of the sequence 
of the DNA, which carries information ranging from single nucleotide variations to 
larger structural changes such as copy number variations, large deletions and 
insertions, and their subsequent annotation (Del Giacco and Cattaneo, 2012). 
Transcriptomics is the term given to the qualitative and quantitative study of 
complete sets of transcripts, including coding and non-coding, within an organism 
(Chang, 2016). Due to the closer relationship between transcripts and proteins, and 
thus to the phenotype in comparison to the genome, transcriptomics is often the 




discovery efforts. Phenomena such as alternative splicing and RNA editing are some 
of the difficulties that are faced upon studying whole transcriptomes. Current 
developments in the field of transcriptomics focus on studying the transcriptome of 
single cells. Such efforts aim to identify cellular subpopulations, determine whether 
detected changes are due to real cellular phenotypes or proliferation, investigate 
processes such as cellular differentiation and study rare populations of circulating 
tumor cells or cancer stem cells (Kanter and Kalisky, 2015; Trapnell, 2015; Chen, 
Ning and Shi, 2019). 
Proteomics allows the study of entire proteomes and relative quantitative 
comparisons over various conditions with comprehensive proteome coverage 
(Mishra, 2010). It promises to provide a more complete description of the cellular 
state, since it informs the researcher about the end-point of the expression cascade, 
and the amounts and properties of proteins (Cox and Mann, 2011; Altelaar, Munoz 
and Heck, 2013; Aebersold and Mann, 2016). Two major types of proteomics 
strategies are bottom-up (Wolters, Washburn and Yates, 2001; Sinitcyn, Rudolph 
and Cox, 2018) and top-down proteomics (Marshall, 2006; Toby, Fornelli and 
Kelleher, 2016; Fornelli et al., 2017). The bottom-up proteomics approach based on 
liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) 
techniques, often named shotgun proteomics, aims to measure digested proteins 
(peptides) since measuring intact proteins has proven to be cumbersome (Zhang et 
al., 2013). Some of the difficulties in measuring intact proteins via mass 
spectrometry, so-called top-down proteomics, include highly complex spectra which 
are hard for deconvolution algorithms to handle due to the majority of ions within 
the sample being multiply charged, and the sample preparation hurdles that arise 
from having to deal with intact proteins, especially insoluble ones (Brown et al., 
2020). For bottom-up proteomics, the proteins are first digested using a protease. 
Trypsin is often the protease of choice because of its high fragmentation efficiency, 
suitable peptide length for HPLC separation and the fact that it cleaves peptides on 
the C-terminal side of lysine and arginine residues (both of which carry a positive 
charge), which is useful for the ionization of the peptides (Aebersold and Mann, 
2003). 
Metabolomics aims to study the entire set of small molecules, typically <1500 
Daltons (Da) in mass, known as metabolites within an organism, tissue or cell 
(Weckwerth, 2007). Since metabolites are the omics level closest to the phenotype of 




function of the underlying biological mechanisms governed by genes, transcripts and 
proteins. Similar to proteomics, LC-MS/MS is the analytical platform of choice for 
metabolomics studies. LC-MS/MS-based technologies due to the increased 
sensitivity and potential for detecting novel unknown metabolites can cover a larger 
portion of the metabolome (Stringer et al., 2016). The ultimate goal in metabolomics 
is to detect and quantify metabolites similar to expression analysis in transcriptomics 
or proteomics. By far the largest metabolomics data repository is the MetaboLights 
database (Haug et al., 2013). 
Genomics, transcriptomics, proteomics and metabolomics data is further 
divided into data that focuses only on a certain aspect of each of the aforementioned 
biomolecules. These areas of focus are typically the various chemical modifications 
that can be found on such biomolecules, which are known to have a functional 
significance. These include epigenetic modifications such as methylation 
(Rauluseviciute, Drabløs and Rye, 2019), alternative splicing in the case of the 
transcriptome (Ding, Rath and Bai, 2017), post-translational modifications (PTMs) 
on proteins (Larsen et al., 2006) and structural variations in metabolites (Figure 1.3) 
(Dettmer, Aronov and Hammock, 2007). Several different analytical techniques and 
technologies are utilized for the generation of omics datasets, with the most popular 
being next generation sequencing (NGS) for genomics and transcriptomics, and LC-
MS/MS for proteomics and metabolomics (Kandpal, Saviola and Felton, 2009). 
Proteomics and metabolomics based on LC-MS/MS still need further development 
to reach the level of genomics and transcriptomics, at both the technical and data 
analysis level (Smith et al., 2014). In this section, the analytical platforms of choice 
for genomics and transcriptomics (NGS), and proteomics and metabolomics (LC-





Figure 1.3: Various omics dimensions with two major analytical platforms, namely 
NGS and LC-MS/MS are shown. Each of the major omics data also have several 
subdivision such as secondary modifications in genomics, transcriptomics and 
proteomics, along with others such as localization in the case of proteomics. 
1.1.1 Next Generation Sequencing 
The analytical platform of choice for genomics and transcriptomics is NGS (Wang, 
Gerstein and Snyder, 2009; Koboldt et al., 2013). It can arguably be considered the 
first spark in the data revolution in biological research. During the past two decades, 
scientists have been able to decipher the genome and transcriptome of many 
organisms from different domains of life using NGS technologies, which have now 
reached a level where improvements are incremental in both the hardware and 
software utilized (Giannopoulou et al., 2019). It has quickly replaced microarrays and 
has been rapidly adapted to the clinic mainly due to ultra-high throughput, 
scalability, robustness and speed when compared to previous techniques such as 
Sanger sequencing or microarrays, paving the way for the increasing availability of 
personalized medicine (Hurd and Nelson, 2009). NGS empowers the average lab to 




This is a huge feat when compared to Sanger sequencing which would require over a 
decade to deliver such data (Lander et al., 2001) or microarrays, which are limited in 
their capacity to capture the entire genome on a single chip (Bumgarner, 2013). NGS 
owes its success largely to smart bioinformatics solutions, which are essential for 
constructing the genome in question from millions of fragments that are sequenced 
in parallel (Behjati and Tarpey, 2013). Whole genomes can now be easily sequenced 
and stored along with annotation information in publically available databases 
(Mailman et al., 2007; Kodama, Shumway and Leinonen, 2012; Clough and Barrett, 
2016). The sequencing of the human genome (Lander et al., 2001) set the stage for 
omics studies of many kinds. 
1.1.2 Liquid Chromatography Coupled with Tandem Mass 
Spectrometry 
The most widely used analytical platform for proteomics and metabolomics is LC-
MS/MS (Blum, Mousavi and Emili, 2018). It provides data in three dimensions, m/z 
(mass to charge ratio), retention time and intensity. Recent extensions of the LC-
MS/MS setup (Figure 1.4), such as the FAIMS interface (ion mobility) (Hale et al., 
2020) add a fourth dimension to the data, which will not be covered here. In the 
classical LC-MS/MS setup, sample preparation, which may also include protein, 
peptide, metabolite or lipid fractionation and enrichment, is followed by high 
performance liquid chromatography (HPLC) and subsequently by mass 
spectrometry (MS) data acquisition. The generated raw data is then processed and 
analyzed to identify and quantify the features of interest (Sinitcyn, Rudolph and Cox, 
2018). 
 
Figure 1.4: Basic LC-MS/MS setup. 
Various fields of analytical chemistry utilize HPLC as an efficient method for 
separating, identifying and quantifying components in liquid mixtures (Dahimiwal 
et al., 2013). The basic principle used in this technique is pumping liquid containing 




suitable solid adsorbent. The system then relies on varying interactions between the 
compounds in the liquid mixture and the adsorbent material, which would in turn 
alter the flow rate of the liquid mixture and thus separate the components going 
through the adsorbent packed column (Figure 1.5). The HPLC is used to derive the 
retention time of the ions, which is the time measured from sample injection to the 
HPLC and the appearance of the maximum signal for the ion post chromatographic 
separation (Katajamaa and Orešič, 2005). In the case of proteomics, purified proteins 
or peptides are separated after digestion with nanoliter per minute flow rates with 
the HPLC, prior to being introduced to MS analysis via electrospray ionization 
(Figure 1.6) (Hein et al., 2013). It is estimated that complex digested proteome 
samples may contain well over a hundred thousand unique peptides (Michalski, Cox 
and Mann, 2011; Nagaraj et al., 2011). Such complex samples cannot simply be 
resolved directly by MS and thus, HPLC is crucial for slower sample introduction, 
allowing the MS to be able to capture and measure as many peptides as possible. To 
this end, the sample is loaded to a chromatographic column, which is usually packed 
with a hydrophobic reverse phase material such as C18. This leads to the peptides 
binding the hydrophobic reverse phase material with different strengths based on 
their chemical properties and thus, be released gradually by increasing the amount 
of the solvent. 
 
Figure 1.5: Basic schema of a HPLC setup. 
The mass spectrometer has been a widely used platform in various field of 
research for measuring the m/z of ions. Measurements are often visualized as a mass 
spectrum where the intensity of an ion is plotted against its m/z ratio (Figure 1.6). 
Different techniques exist, which can be divided into two major groups, MS with trap-




mass analyzer, every mass spectrometer used in LC-MS/MS has three key elements, 
the ion source, the mass analyzer and the detector (Figure 1.4) (El-Aneed, Cohen and 
Banoub, 2009). 
 
Figure 1.6: Basic bottom-up proteomics approach leading to MS and MS/MS mass 
spectra. 
One goal in further developing new mass spectrometers is to reach a machine 
capable of higher resolution measurements. Resolution is the ability to distinguish 
two features corresponding to two different ions with very similar m/z ratio 
(Scigelova et al., 2011) and is calculated as the ratio of a features’ m/z, and the delta 
m/z at the full width half maximum (FWHM) of that feature (Marshall and 
Hendrickson, 2008). Another goal is to reach better mass accuracy, which is the 
deviation between the theoretical mass and the experimentally determined mass of 
ion. Mass accuracy is influenced by the resolution of the mass spectrometer and the 
signal to noise ratio within the MS data (G. Marshall et al., 2013). Furthermore, it is 
important to have a mass spectrometer that not only detects highly abundant ions, 
but also capable of detecting low abundant ions in complex mixtures. This is known 
as the dynamic range. The scan speed is also important as it defines how fast a certain 
m/z range can be scanned, which is mostly inversely correlated with the resolution of 
the mass spectrometer (Wu and Han, 2006). Finally, new mass spectrometers aim 
for higher sensitivity, which is measured by the intensity of the MS signal for a certain 
concentration of the sample. Many different operation modes exist for mass 
spectrometers. In its targeted mode, a predefined target mass range is set with the 
aim of reaching the highest possible quantitative accuracy and reproducibility (Marx, 
2013). On the other hand, DDA and DIA mass spectrometry (Zhang et al., 2013, 
2020) aim to capture the largest possible spectrum, both of which will be discussed 
later in the chapter. 
The latest game-changing mass spectrometer technology introduced is the 




which is similar to Fourier transform ion cyclotron resonance mass spectrometers 
(FTMS) in its working principle, where ions are trapped using an electrostatic force 
and thus orbit around a small spindle shaped electrode (Figure 1.7). This electrode is 
designed in a manner that the orbiting ions are not only confined in their orbit, but 
also oscillate along the length of the electrode. The oscillation is used to obtain what 
is called an image current in the detector plates of the Orbitrap, which is subsequently 
recorded by the mass spectrometer. Since the frequencies of the image currents are 
related to the m/z ratios of the ions, the relevant mass spectra can be obtained from 
performing Fourier transformation on them (Hu et al., 2005; Scigelova et al., 2011). 
The Orbitrap is with its innovative working principle is the latest addition to the array 
of different types of mass analyzers that are utilized in modern mass spectrometers. 
It was introduced almost two decades ago (Makarov, 2000), and has been quickly 
adopted by biologists as the go to platform for proteomics and metabolomics studies. 
Its success is due to higher resolution, high mass accuracy and a large dynamic range 
(Hu et al., 2005; Makarov et al., 2006). 
 
Figure 1.7: The structure of the Orbitrap mass analyzer. 
1.2 Computational Proteomics 
Advancements in proteomics technologies have been rapid and thus, effective in 




2008, 2011; Aebersold and Mann, 2016), but many areas are still in need of further 
development. These include computational methods for data processing and analysis 
(C. Chen et al., 2020) and some of the most important advancements in this direction 
are computational platforms and workflows such as MaxQuant and Perseus (Cox and 
Mann, 2008; Cox et al., 2011; Tyanova et al., 2016; Sinitcyn et al., 2018). MaxQuant 
is a software suit, which provides an easy and intuitive means for performing 
quantitative proteomics data analysis for large LC-MS/MS data sets, and Perseus 
provides an intuitive and user-friendly platform for the downstream analysis of 
MaxQuant outputs. 
 Peak detection within the spectra generated by MS is an important initial step 
in computational proteomics (Zhang et al., 2009), and with the introduction of 
higher resolution MS machines, it has been possible to resolve the isotope pattern 
and even fine structures of peptides (Miladinović et al., 2012). The peak information 
(m/z and intensity) coupled to the retention time information from HPLC become 
3D features (Figure 1.8). These features are then taken and assembled to construct 
isotope patterns. This information when combined, lead to considerably high mass 
precision, but this is not necessarily true for mass accuracy, primarily due to 
systematic errors that occur during MS measurements. Such errors have been 
observed to be typically nonlinear and dependent on m/z, retention time, and signal 
intensity. In case of LC-MS/MS coupled with ion mobility, the ion mobility index also 
has an effect on the mass error (Sinitcyn, Rudolph and Cox, 2018). MaxQuant was 
first introduced with an effective algorithm for tackling the mass error problem using 
a multivariate nonlinear recalibration algorithm, which takes advantage of the many 
peptides within complex proteomics samples as calibration points, resulting in 
significant increases in mass accuracy  (Cox and Mann, 2008, 2009; Cox, Michalski 
and Mann, 2011). Besides mass accuracy, in order to ensure consistent retention time 
values and ion mobility orders for peptides across different runs, similar 
recalibration strategies are employed. This is important since HPLC and ion mobility 
setups are naturally prone to irreproducibility, causing problems when comparing 
different LC-MS/MS runs (Sinitcyn, Rudolph and Cox, 2018). Following these 
recalibration steps, it is possible to transfer identifications across different runs and 
compare several different runs together (Paša-Tolić et al., 2004), which is especially 
useful to tackle the stochastic nature of DDA methods in peptide fragmentation 





Figure 1.8: 3D peak information. 
The fragmentation spectra obtained after the initial MS scan are analyzed in 
order to sequence the peptides. This is done most frequently using a database search 
engine approach, where the database contains all theoretical peptide fragmentation 
spectra generated in silico, using whole genome information (Craig and Beavis, 
2004; Geer et al., 2004; Cox et al., 2011). Such approaches match the measured 
fragmentation spectrum to the entries within the database considering a certain mass 
tolerance. Each such match is named a peptide-spectrum match (PSM), and to 
control for false positive PSMs, a target-decoy approach is employed (Elias and Gygi, 
2007), where in addition to the target database of all theoretical peptide 
fragmentation spectra, a decoy database is constructed. The decoy database often 
contains the reverse sequences of the target database and matches are labeled as 
false-positive PSMs. The score distributions of the PSMs from the target and decoy 
databases can then be used to calculate posterior error probabilities, and control for 
the false discovery rate (FDR) along with other peptide features such as peptide 
length and number of missed cleavages (Cox and Mann, 2008). After peptide 
identification, the peptides are assembled into proteins. The main challenge in this 
step is that during protein digestion many peptides are digested from a protein and 
many peptides are not unique to a certain protein, thus, there is a many-to-many 




After peptide identification and protein assembly, the proteins can then be 
quantified. Protein quantification can be either absolute or relative. Absolute 
quantification aims to determine the quantity of a protein within a certain sample, 
whereas relative quantification deals with determining the ratio of the protein 
quantity between samples (Figure 1.9). Quantification strategies can be based on 
using labels, e.g. using stable isotopes to tag peptides, or be performed in a label-free 
manner. Relative label-free quantification (LFQ) is challenging due to the nature of 
LC-MS/MS data. These challenges include retention time differences between LC-
MS/MS runs due to parallel sample handling and irreproducibility of HPLC, 
stochastic MS/MS sequencing as the mass spectrometer chooses the most abundant 
peptides for MS/MS leading to missing peptide identifications across samples, and 
pre-fractionation causing peptides to appear in several fractions. MaxQuant, 
equipped with the MaxLFQ algorithm, overcomes such challenges via nonlinear 
retention time alignment, peptide identification transfer between different runs and 
peptide intensity normalization across fractions (Cox et al., 2014). In term of absolute 
quantification, MS is not inherently quantitative due to the vastly different behavior 
of peptides within the mass spectrometer, and the strong correlation of the MS signal 
with the input amount of the protein. To overcome these challenges, Perseus is 
equipped with the Proteomic Ruler plugin, which uses the histone signals identified 
within the MS run as a scale with respect to the amount of DNA measured in the 
sample, to estimate protein copy numbers (Wiśniewski et al., 2014). 
 
Figure 1.9: Absolute and relative protein quantification. The vertical yellow shaded bar 
depicts absolute quantification within a sample and the horizontal blue shaded line depicts 
relative quantification across different samples. 
Computational proteomics has been a corner stone of proteomics studies 
(Sinitcyn, Rudolph and Cox, 2018). Its ultimate goal is to process and analyze the 




studying comparative changes between different conditions, posttranslational 
modifications, protein-protein interactions, and the subcellular localization of 
proteins. Generally, endeavors in computational proteomics can be divided into two 
major groups, the correct identification and precise quantification of proteins, and 
the detailed analysis of this information within the context of the specific biological 
question. To this end, bioinformaticians have to develop various algorithms for 
handling the different types of LC-MS/MS data acquisition methods. In the following 
two sections, DDA and DIA proteomics approaches will be discussed.  
1.2.1 Data Dependent Acquisition 
One of the most mature acquisition methods in proteomics is data dependent 
acquisition (DDA) (Dupree et al., 2020). It is the most widely adapted method for 
proteomics studies, in which ions are separated after the first MS scan based on their 
m/z, and the instrument then selects certain ions in real-time with specific m/z 
values for further analysis after fragmentation (MS2) (Figure 1.10). Subsequent 
fragmentation techniques post precursor ion selection vary, and can be any of 





Figure 1.10: Schematic overview of data dependent acquisition proteomics (adapted from 
(Wolf-Yadlin, Hu and Noble, 2016)). 
Using DDA, the mass spectrometer is set to select a subset of ions based on 
MS1-level data, usually the most abundant ions, for further analysis via MS2. This is 
why DDA is also sometimes named the topN method (Venable et al., 2004). Higher 
abundant ions are preferred, since they usually lead to higher quality MS/MS spectra, 
leading to a higher number of identifications (Hebert et al., 2018). In this step, the 
mass spectrometer uses ion fragmentation and tandem measurement to deliver 
further information on the ion in question. In the case of peptides, the fragmentation 
energies are set in a way that they are most optimized for single peptide backbone 
breakages, leading to a set of complementary fragment ions. DDA has improved with 
each new generation of mass spectrometers to capture more ions, leading to efficient 
capture of effectively a complete proteome even with a single run MS run (Bekker-




1.2.2 Data Independent Acquisition 
The LC-MS/MS method for studying proteins, especially in its DDA form for shotgun 
proteomics has allowed for the in-depth analysis of entire proteomes. In efforts to 
make proteomics techniques a more stable and robust, new methods are being 
developed using DIA. DIA promises to be a faster, thus cheaper alternative to the 
current gold standard that is DDA. In DIA, all ions within a selected m/z range are 
sent for fragmentation for further analysis in the second MS (Figure 1.11). It has been 
in use and constant development during the last two decades, and has continued to 
be utilized and improved, with methods focusing on fragmenting entire precursor 
ranges, also with narrower windows which aim to simulate DDA runs (Panchaud et 
al., 2009, 2011; Geiger, Cox and Mann, 2010b; Egertson et al., 2013). Fragmenting 
entire precursor ranges result in faster data acquisition and thus, help to cover wider 
mass ranges at the cost of higher spectral complexity, and utilizing narrower windows 
lead to less complex spectra with a higher dynamic range at the cost of higher cycle 
times (Chapman, Goodlett and Masselon, 2014). DIA is progressively attracting 
traction for proteomics studies as it promises the advantages of targeted approaches 
to studying complete proteomes, especially in terms of sensitivity and reproducibility 
(Doerr, 2014). DIA strives to overcome the limitation in the number of MS/MS 
spectra that the mass spectrometer is able to measure by isolating certain ions. Since 
in DIA instead of a certain ion, a m/z range is selected for further fragmentation and 
analysis, the resulting MS/MS spectra is essentially a combined spectrum for 
multiple peptide precursors, which would need to be deconvoluted for effective 
peptide identification (Masselon et al., 2000). On the other hand, DIA ensures that 
essentially no data is lost and all precursors are fragmented and thus, it not only 
promises to capture and record the entire proteome in the realm of the mass 
spectrometers maximum dynamic range, but also allows for higher reproducibility 
across different samples (Gillet et al., 2012). Although in theory DIA has been 
proposed to have many advantages over the current DDA approaches, in practice it 
has so far not been able to compete with DDA in terms of whole proteome coverage 
(Röst et al., 2014; Navarro et al., 2016; Collins et al., 2017). Perhaps this is mainly 
due to the lack computational workflows, which can effectively decipher the data to 
reach higher rates of identification and reliable quantification. Initial computational 
solutions for the analysis of the data were focusing on generating so called pseudo-
MS/MS spectra, where fragment ions were grouped based on retention time 




(Bilbao et al., 2015). MaxQuant equipped with MaxDIA, utilizes two different 
strategies for the analysis of DIA data based on both experimentally generated 
libraries using DDA methods and predicted libraries, which is further discussed in 
detail in section 4.2. 
 
Figure 1.11: Schematic overview of data independent acquisition proteomics (adapted 
from (Wolf-Yadlin, Hu and Noble, 2016)). 
1.3 Computational Metabolomics 
The latest LC-MS/MS platforms can measure well over 200,000 ions within each run 
from typical biological samples, from which only a fraction of a percent are identified. 
Computational workflows for such metabolomics data aim to reach higher mass 
accuracy and effectively use information such as chromatographic retention time, 
collision-induced dissociation products and collision cross section for metabolite 




metabolomics data designed to deal with the various aspects of the complexity of the 
data ranging from peak detection to spectral noise removal and feature alignment 
between different runs (Tautenhahn, Bottcher and Neumann, 2008; Yu et al., 2009; 
Pluskal et al., 2010).  
Peak detection is done in a per file fashion with certain criteria such as signal-
to-noise ratio and peak shape used to filter for peaks of high quality. This is followed 
by alignment strategies to create a dataset of all peaks contained within all files so to 
compensate for deviations and errors across LC-MS/MS runs. Such deviations and 
errors occur especially within the retention time dimension, which could arise from 
HPLC variables such as column temperature and the pressure within the system 
along with the changes within the column during the course of the runs (Lange et al., 
2008). Deviations could also arise during mass spectrometry and technical replicates 
are important to detect and account for such deviations (Uppal et al., 2013; Libiseller 
et al., 2015). One of the most important factors in metabolomics data analysis is mass 
accuracy. Since mass accuracy has a direct influence on the quality of alignment 
between samples, downstream feature annotation and metabolite identification, low 
mass accuracy jeopardizes the entire analysis (Kind and Fiehn, 2006). To this end, 
mass error correction strategies exist that exploit internal standards and references, 
which can estimate the error, and account for it downstream for improving 
alignments between different runs (Shahaf et al., 2013). Such strategies are effective 
to a degree, but due to the limited amount of standards and references, it is often 
difficult to account for the mass error across the entire mass range of the 
measurements. The following section discusses these limitations along of with some 
lessons from proteomics and possible solutions. 
1.3.1 What Computational Non-Targeted Mass Spectrometry-
Based Metabolomics can gain from Shotgun Proteomics 
In the following review article (Hamzeiy and Cox, 2017), the common challenges 
between computational proteomics and metabolomics are discussed with a focus on 
how these challenges are met in the realm of proteomics, and how such strategies can 
be adapted to the field of metabolomics. It is argued that similar to the effect of higher 
mass accuracies in proteomics datasets where higher rates of identification are 
achieved, metabolomics datasets would also benefit from a smart mass recalibration 




 Contributions to the following review within the context of this thesis include 
the gathering and organizing of all publicly available metabolomics data for 
preliminary testing of the mass recalibration strategy proposed for metabolomics 
datasets, taking part in the implementation of the algorithm, testing and 
benchmarking, and writing the review. 
Hamzeiy, Hamid, and Jürgen Cox. 2017. “What Computational Non-Targeted 
Mass Spectrometry-Based Metabolomics Can Gain from Shotgun Proteomics.” 
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1.4 Multi-Omics Data Analysis 
Arguably, the most challenging task is to take what are in essence snapshots of the 
state of a biological system under study, and combine them in a manner from which 
meaningful information could be extracted (Subramanian et al., 2020). There are 
many reasons for studying more than one omics dataset simultaneously. The main 
challenge in such efforts, besides the handling of the huge amounts of data generated, 
is the heterogeneous and multidimensional nature of the data since each omics 
dimension is measured using a different technology, and is presented in a unique 
manner (Kim and Tagkopoulos, 2018). These differences can arise from the nature 
of the data, e.g. being discrete or continuous, or from the complexity of the measured 
omics dimension, e.g. the expression levels of tens of thousands of mRNAs, and the 
levels of thousands of metabolites, not to mention the differing sensitivity and 
reproducibility of each different technology. On the other hand, multi-omics efforts 
can be helpful in reducing noise and false positive findings within each omics 
dimension by aggregating data and evidence from several different layers of 
information (Rotroff and Motsinger-Reif, 2016).  
Cross analysis of proteomics data with genomics data can correlate 
personalized hereditary or disease-related information to proteomic phenomena, 
such as correlating DNA copy number and loss of heterozygosity to protein 
expression by grouping together proteins matching to the same gene (Geiger, Cox 
and Mann, 2010a). By comparing the transcriptome to the proteome, the dynamic 
phenomena of gene expression between transcription and translation becomes 
detectable. When combining proteomics and transcriptomics data, expression levels 
may be the easiest to integrate due to their near 1:1 relationship (Tyanova et al., 
2016). An even closer relationship exists between transcriptomics and proteomics 
when one considers data from techniques such as ribosome profiling (Ingolia, 2014). 
Metabolomics data combined with proteomics data bears the possibility to study the 
interplay of enzymes with reaction reactants, since metabolites and proteins have an 
organic connection via metabolic reactions where enzymes are responsible for the 
consumption and production of metabolites. Metabolites can also act as catalysts, 




1.4.1 Network Assisted Data Analysis 
When analyzing data from different levels of omics, existing knowledge regarding 
established relationships between various biomolecules ranging from DNA to 
metabolites promises a logical approach to integrating such data (Y. X. Chen et al., 
2020). Many public databases are now available where data is curated by mining 
literature, where various interactions are intuitively represented as networks 
(Orchard et al., 2014; Szklarczyk et al., 2019; Oughtred et al., 2020). Metabolic 
networks reconstructed on the level of various organisms provide a great opportunity 
to integrate various omics data and analyze them together (Büchel et al., 2013). This 
is because the metabolome is the closest level to the phenotype of the organism of 
interest. The metabolic network provides the scaffold upon which all omics data can 
be mapped for integrative analysis (Chong and Xia, 2017). Such an approach in 


















Within the context of this thesis, several project have been carried out in aims of 
improving computational methods for LC-MS/MS-based proteomics, metabolomics, 
and downstream analysis of multi-omics datasets. To this end, a new algorithm is 
proposed for improved mass accuracy in LC-MS/MS-based metabolomics datasets, 
which incorporates a novel library-based mass recalibration approach. This will in 
turn help increase the number of identifications in future metabolomics software and 
help propel metabolomics to the level of maturity that proteomics has reached. 
Furthermore, MaxQuant 2.0 equipped with MaxDIA is described for analyzing DIA 
LC-MS/MS proteomics datasets, using both measured libraries and predicted 
libraries. This further expands the abilities of the MaxQuant platform as the go to 
platform for the quantitative analysis of proteomics datasets. Finally, the Metis 
plugin for the Perseus software is introduced as an easy and accessible tool for 
metabolic network-based multi-omics analysis. Metis expands the capabilities of the 
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Here, the primary results on the improvement of mass accuracy in LC-MS/MS-based 
metabolomics data is presented. Later in chapter 4, the relevant publications to the 
improvements of the MaxQuant software suit in terms of supporting the Linux 
operating system and DIA proteomics data is presented, along with the Metis plugin 
for multi-omics data analysis within the Perseus software suit. 
3.1 Metabolomics Library Generation 
In order to generate a the initial library to use for mass recalibration in metabolomics, 
m/z values which are known common metabolites in biological samples from 
databases such as ChEBI (de Matos et al., 2010), which accumulate and curate 
metabolites of biological importance are gathered. It is important to mention that the 
library is made up of all possible isotopic peaks, rather than simply monoisotopic 
masses for the metabolites, since features are to be matched to the library rather than 
isotope patterns. Subsequently, publically available metabolomics data from several 
resources, including MetaboLights (Haug et al., 2020) and Metabolomics 
Workbench, were gathered and filtered for data from Orbitrap mass spectrometers, 
due to the higher resolution that this type of mass spectrometer provides for the lower 
mass range. This resulted in 71 datasets corresponding to 1511 runs. All data were 
then processed using the MaxQuant software for feature detection and using our 
novel mass morphing algorithm, features are mapped to the library. The library can 
then be updated if there remains unmapped features with adequate signal-to-noise 
ratio with a plausible new metabolite annotation (Figure 3.1). 
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Figure 3.1: Metabolite library generation workflow. 
Following the library generation and update strategy, the size of the library 
increases as newly identified high quality features within each dataset that are not 
present within the library of plausible m/z values are added to the library, making 
the library more comprehensive. This behavior plateaus as the library is updated with 
each iteration of processing the same dataset and will continue with every new 
dataset (Figure 3.2). 
 
Figure 3.2: Library size increases with subsequent mapping and mass morphing and 
plateaus after several iterations on four datasets. The y-axis is the number of m/z vales 





The number of identified features within each dataset decreases as the growth 
of the library leads to higher mass accuracy and thus, more confident identifications. 
This is not the case for the initial dataset used to develop the algorithm and the initial 
library as many of the features within that dataset were initially manually identified 
(Figure 3.3). 
 
Figure 3.3: Number of identified features within four different mass spectrometry runs. 
The y-axis is the number of identified and the x-axis is the number of iterations of mass 
recalibration. 
3.2 Library mapping, mass morphing and recalibration 
We use our Easy Library Implementation (ELI) for mass recalibration in 
metabolomics, for a significant improvement in mass accuracy of metabolomics 
datasets. After generation of the library of plausible m/z values, the mass 
spectrometry run to be analyzed is processed and aligned to the library using our 
mass morphing approach, which calculates a nonlinear calibration function aiming 
to map as many features to the library as possible. Special attention is made to the 
smoothness of the fit to prevent overfitting (Figure 3.4). 




Figure 3.4: Schema of how features are mapped and morphed to the library. 
ELI for mass recalibration in metabolomics when performed on all 1511 
metabolomics runs that were gathered results in a general improvement across all 
datasets with the median mass error being reduced, with significant improvements 
in datasets which were suffering from high rates of mass error (Figure 3.5). Although 
mass accuracy improvements depends on factors such as molecular mass and the 
complexity of the sample, improvements in mass accuracy generally lead to the 
reduction of the number of candidates for each feature and thus, help in the effective 





Figure 3.5: Average FWHM of un-calibrated vs. calibrated delta ppm across 1511 
metabolomics runs. The mass error is significantly reduced in datasets that suffered from 










During the past few years, we have published papers on improvements to the 
MaxQuant software suit, multi-omics capabilities of the Perseus software suit and the 
introduction of MaxQuant 2.0, which will be presented in the following sections. 
4.1 MaxQuant goes Linux 
MaxQuant has been accepted by the proteomics community as the gold standard in 
analyzing proteomics data for more than a decade. However, due to its Windows only 
structure and the limitations of Windows in running powerful servers with many 
hundreds of CPU cores, many larger proteomics projects suffered from lengthy run 
times. Adapting the MaxQuant code base to Linux-based operating systems has not 
only allowed larger proteomics projects to be processed on larger servers running 
Linus-based operating systems, it has also allowed the more advanced MaxQuant 
user to utilize MaxQuant in custom scripts and workflows for streamlined analysis. I 
have been privileged to be part of the team involved in this development in the 
MaxQuant ecosystem by contributing to the transition to Linux and testing its 
performance.  
 Contributions to the following correspondence within the context of this 
thesis include software development and research into cross platform software 
development strategies. 
Sinitcyn, Pavel, Shivani Tiwary, Jan Rudolph, Petra Gutenbrunner, Christoph 
Wichmann, Şule Yllmaz, Hamid Hamzeiy, Favio Salinas, and Jürgen Cox. 2018. 
“MaxQuant Goes Linux.” Nature Methods 15 (6): 401. 
https://doi.org/10.1038/s41592-018-0018-y. 
[Grab your reader’s 
attention with a great quote 
from the document or use this 
space to emphasize a key 
point. To place this text box 






MaxDIA enables highly sensitive and accurate library-based and library-free 
data-independent acquisition proteomics 
45 
 
4.2 MaxDIA enables highly sensitive and accurate 
library-based and library-free data-independent 
acquisition proteomics 
MaxQuant 2.0 follows in the lineage of the original MaxQuant software published 
more than a decade ago, which has become the gold standard go to software for the 
processing of raw LC-MS/MS data. Originally, MaxQuant was designed and 
implemented for DDA experiments, and now, analysis of data-independent 
acquisition data can be carried out by the MaxDIA algorithm. In the context of this 
PhD work, all relevant testing data was gathered, benchmarking was performed, 
machine-learning algorithms within the workflow were optimized, external 
collaborations were coordinated, and the following manuscript was written along 
with the other co-authors. 
 Contributions to the following correspondence within the context of this 
thesis include software design and development, software benchmarking, data 
analysis and ensuring support for external resources such as the PRIDE repository. 
Pavel Sinitcyn, Hamid Hamzeiy, Favio Salinas Soto, Daniel Itzhak, Frank 
McCarthy, Christoph Wichmann, Martin Steger, Uli Ohmayer, Ute Distler, Stephanie 
Kaspar-Schoenefeld, Nikita Prianichnikov, Şule Yılmaz, Jan Daniel Rudolph, Stefan 
Tenzer, Yasset Perez-Riverol, Nagarjuna Nagaraj, Sean J. Humphrey and Jürgen 
Cox. “MaxDIA enables highly sensitive and accurate library-based and library-free 
data-independent acquisition proteomics.” Submitted to Nature Biotechnology, 
2020 
[Grab your reader’s attention with a great quote from the document 
or use this space to emphasize a key point. To place this text box anywhere 





MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 









MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








MaxDIA enables highly sensitive and accurate library-based and library-free 








Perseus plugin ‘Metis’ for metabolic pathway-centered quantitative multi-
omics data analysis supporting static and time-series experimental designs 
115 
 
4.3 Perseus plugin ‘Metis’ for metabolic pathway-
centered quantitative multi-omics data analysis 
supporting static and time-series experimental 
designs  
Time-series omics data, available from circadian studies provide a unique 
opportunity to infer new knowledge on dynamic biological processes by applying 
multi-omics data analysis techniques. We take mice liver transcriptomics, 
proteomics, phosphoproteomics, metabolomics, and lipidomics circadian data and 
by utilizing a network-based method using a large-scale metabolic network 
reconstruction provided by the BioModels database, we look for enzyme activity 
regulation. In the context of this PhD work, data were gathered from different sources 
and processed in a suitable manner, all necessary design, implementation of the 
Perseus code-base was executed, and the following manuscript was written along 
with the other co-authors. 
 Contributions to the following correspondence within the context of this 
thesis include the design and implementation of the network-based multi-omics data 
analysis approach, data analysis and writing of the manuscript. 
Hamid Hamzeiy, Daniela Ferretti, Maria S. Robles, and Jürgen Cox. “Perseus 
plugin ‘Metis’ for metabolic pathway-centered quantitative multi-omics data analysis 
supporting static and time-series experimental designs.” Submitted to Cell Systems, 
2021 
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Table 1. Datasets used in this study. Details of the five omics datasets of 
circadian mouse liver entrained in day-night cycles and then free running from time 
point 0. Several details of the time series acquisition, such as the total acquisition 
time, the sampling rate and the number of replicates per time point vary. Cycling q-
values differed between the analyses performed in the respective publications. In 
order to keep consistency with previous work, we applied the cycling q-value that 
was used in each publication. 
Paper 
Hughes, 
M. E. et 
al. 2009 
Robles, M. S., 
Cox, J. & 
Mann, M. 
2014 
Robles, M. S., 
Humphrey, S. J. & 
Mann, M. 2017 
Krishnaia
h, S. Y. et 
al. 2017 
Adamovi
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 Conclusion and Outlook 
The rapidly evolving fields of omics, computational biology and multi-omics are 
fueling the data-driven revolution of the exploration of biological systems, which has 
had an immense impact on our understanding of the underlying mechanisms of 
living organisms. MaxQuant and Perseus have been continuously developed and 
widely accepted as trusted software platforms for the processing and analysis of 
shotgun proteomics datasets. These platforms house a wealth of tools and algorithms 
that can handle various aspects of the data and provide a user-friendly graphical 
interface. Expanding these platforms to various operating systems others than their 
native Microsoft Windows environment and their abilities in analyzing other types of 
proteomics data such as DIA and metabolomics datasets, provide an substantial 
added value as researchers are enabled to do more and with higher flexibility with 
software that they already use and know well.  
MaxQuant is equipped with ELI for mass recalibration in metabolomics, 
which is the first step in developing MaxQuant as an all-in-one solution for 
metabolomics studies, similar to the position of MaxQuant in proteomics. Achieving 
higher mass accuracies in proteomics data has proven to be of paramount importance 
in increasing the coverage of the proteome and robustness of the approach, and 
similar benefits can be expected for metabolomics datasets. In addition, many of the 
universal functionalities of MaxQuant for LC-MS/MS data can also be readily 
transferred to the processing of metabolomics datasets, accelerating the development 
process. 
Ever since the introduction of MaxQuant in 2008, it had remained a 
Microsoft Windows only software. With increased quantities of proteomics data 
becoming available, bioinformatics facilities began to include MaxQuant in their 
arsenal of frequently used tools. This made the need to release a Linux version of 
MaxQuant evident. Currently, MaxQuant runs on Windows and Linux operating 
systems. 
Historically, MaxQuant has always been the preferred software for the 
analysis of DDA shotgun proteomics data, primarily due to its superior performance 
and ease of use. With the advancements and popularization of DIA methods for 
proteomics studies, the community lacked a reliable and free software for DIA data 
and thus, MaxQuant is now equipped with MaxDIA as a one stop DIA data processing 
solution. MaxDIA is capable of analyzing a wide variety of DIA data ranging from 
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BoxCar-DIA to ion mobility DIA data. It achieves comprehensive proteome coverage 
and precise quantification across many runs. Future developments of MaxDIA will 
focus on expanding the workflow to support PTMs; especially with respect to their 
correct localization within the peptide sequence. 
Although Perseus was initially designed primarily for the downstream 
analysis of MaxQuant outputs, its popularity, flexibility and user-friendly approach 
for analyzing data, has made it popular for use in analyzing other omics datasets, e.g. 
transcriptomics. In this direction, Perseus is continuously developed to allow for 
various other types of data such as NGS data and biological networks. Users can now 
also integrate their own scripts written in Python or R and develop their own plugins 
in C#. With the addition of Metis, a plugin for multi-omics data analysis using 
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